Citations

Showing 10 of 108094 citations.

The marginal fit of lithium disilicate crowns: Press vs. CAD/CAM
Azar, Basel , Eckert, Steve, Kunkela, Josef, Ingr, Tomáš , Mounajjed, Radek

Mayo Clinic

Brazilian Oral Research | January 21, 2018 | Volume: 32 | Pages: No page available

10.1590/1807-3107/2018.vol32.0001 | PMID 29364328 Get It

Comparison of tricuspid annular plane systolic excursion with fractional area change for the evaluation of right ventricular systolic function: a meta-analysis
Lee, Justin Z. , Pasha, Ahmed K. , Howe, Carol , Lee, Kwan , Suryanarayana, Prakash, Low, See‐Wei , Lee, Kwan S

Mayo Clinic

Open Heart | January 20, 2018 | Volume: 5 | Issue: 1 | Pages: e000667

10.1136/openhrt-2017-000667 | PMID 29387425 Get It

Background Accurate determination of right ventricular ejection fraction (RVEF) is challenging because of the unique geometry of the right ventricle. Tricuspidannular plane systolic excursion (TAPSE) and fractional area change (FAC) are commonly used echocardiographic quantitative estimates of RV function. Cardiac MRI (CMRI) has emerged as the gold standard for assessment of RVEF. We sought to summarise the available data on correlation of TAPSE and FAC with CMRI-derived RVEF and to compare their accuracy. Methods We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov and the Cochrane Library databases for studies that assessed the correlation of TAPSE or FAC with CMRI-derived RVEF. Data from each study selected were pooled and analysed to compare the correlation coefficient of TAPSE and FAC with CMRI-derived RVEF. Subgroup analysis was performed on patients with pulmonary hypertension. Results Analysis of data from 17 studies with a total of 1280 patients revealed that FAC had a higher correlation with CMRI-derived RVEF compared with TAPSE (0.56vs0.40, P=0.018). In patients with pulmonary hypertension, there was no statistical difference in the mean correlation coefficient of FAC and TAPSE to CMR (0.57vs0.46, P=0.16). Conclusions FAC provides a more accurate estimate of RV systolic function (RVSF) compared with TAPSE. Adoption of FAC as a routine tool for the assessment of RVSF should be considered, especially since it is also an independent predictor of morbidity and mortality. Further studies will be needed to compare other methods of echocardiographic measurement of RV function.
DNA damage response
Benarroch, Eduardo E. , Coon, Elizabeth A.

Mayo Clinic

Neurology | January 19, 2018 | Volume: 90 | Issue: 8 | Pages: 367-376

10.1212/wnl.0000000000004989 | PMID 29352098 Get It

Excessive Daytime Sleepiness Independently Predicts Increased Cardiovascular Risk After Myocardial Infarction
Xie, Jiang , Covassin, Naima , Singh, Prachi , Gami, Apoor S., Chahal, C. Anwar A. , Sert Kuniyoshi, Fatima H, Chahal, Choudhary Anwar A , Kuniyoshi, Fatima H. Sert , Somers, Virend K. , Singh, Prachi

Mayo Clinic

Journal of the American Heart Association | January 19, 2018 | Volume: 7 | Issue: 2 | Pages: No page available

10.1161/jaha.117.007221 | PMID 29352093 Get It

Background Excessive daytime sleepiness ( EDS ), a common symptom among patients with sleep‐disordered breathing, is closely associated with the development of cardiovascular diseases, but its long‐term prognostic value is not completely understood. The aim of this study was to investigate whether EDS would be an independent prognostic factor after myocardial infarction. Methods and Results We prospectively recruited 112 post–myocardial infarction patients. The Epworth Sleepiness Scale was completed before polysomnography, and EDS was defined as a score ≥11. After exclusion of 8 patients who accepted treatment with continuous positive airway pressure, 104 patients were followed up for 48 months. The primary composite end point was major adverse cardiac events. Patients with EDS had higher rates of major adverse cardiac events (48.4% versus 27.4%, χ 2 =5.27, P =0.022) and reinfarction (29.0% versus 5.5%, χ 2 =13.51, P =0.0002) compared with those without EDS . In the Cox proportional hazards model, patients with EDS had 2.15 times (95% confidence interval, 1.08–4.18; P =0.030) higher crude risk of major adverse cardiac events, with prognostic significance persisting after adjusting for age, diabetes mellitus, depression, left ventricular ejection fraction, apnea–hypopnea index, and nocturnal nadir oxygen saturation (hazard ratio: 2.13, 95% confidence interval, 1.04–4.26, P =0.039). Furthermore, among participants with moderate to severe sleep‐disordered breathing, the presence of EDS was associated with higher risk of major adverse cardiac events than those without EDS , after adjusting for age and nadir oxygen saturation (hazard ratio: 3.17, 95% confidence interval, 1.22–7.76, P =0.019). Conclusions EDS may be an independent prognostic factor of adverse outcome in post–myocardial infarction patients with moderate to severe sleep‐disordered breathing. Evaluation of EDS may shed new light on risk stratification and identify treatment responders for this patient population.
Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon
Graffeo, Christopher S. , Perry, Avital , Link, Michael J. , Graffeo, Christopher Salvatore, Daniels, David J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | January 19, 2018 | Volume: 79 | Issue: 01 | Pages: 065-080

10.1055/s-0037-1621738 | PMID 29404243 Get It

Abstract Pediatric craniopharyngioma is a rare sellar-region epithelial tumor that, in spite of its typically benign pathology, has the potential to be clinically devastating, and presents a host of formidable management challenges for the skull base surgeon. Strategies in craniopharyngioma care have been the cause of considerable controversy, with respect to both philosophical and technical issues. Key questions remain unresolved, and include optimizing extent-of-resection goals; the ideal radiation modality and its role as an alternative, adjuvant, or salvage treatment; appropriate indications for expanded endoscopic endonasal surgery as an alternative to transcranial microsurgery; risks and benefits of skull base techniques in a pediatric population; benefits of and indications for intracavitary therapies; and the preferred management of common treatment complications. Correspondingly, we sought to review the preceding basic science and clinical outcomes literature on pediatric craniopharyngioma, so as to synthesize overarching recommendations, highlight major points of evidence and their conflicts, and assemble a general algorithm for skull base surgeons to use in tailoring treatment plans to the individual patient, tumor, and clinical course. In general terms, we concluded that safe, maximal, hypothalamic-sparing resection provides very good tumor control while minimizing severe deficits. Endoscopic endonasal, intraventricular, and transcranial skull base technique all have clear roles in the armamentarium, alongside standard craniotomies; these roles frequently overlap, and may be further optimized by using the approaches in adaptive combinations. Where aggressive subtotal resection is achieved, patients should be closely followed, with radiation initiated at the time of progression or recurrence—ideally via proton beam therapy, although three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and stereotactic radiosurgery are very appropriate in a range of circumstances, governed by access, patient age, disease architecture, and character of the recurrence. Perhaps most importantly, outcomes appear to be optimized by consolidated, multidisciplinary care. As such, we recommend treatment in highly experienced centers wherever possible, and emphasize the importance of longitudinal follow-up—particularly given the high incidence of recurrences and complications in a benign disease that effects a young patient population at risk of severe morbidity from hypothalamic or pituitary injury in childhood.
Telemedicine in the Management of Type 1 Diabetes
Xu, Timothy T. , Pujara, Shreya, Rhee, Mary K. , Xu, Timothy, Sutton, Sarah W.

Mayo Clinic

Preventing Chronic Disease | January 19, 2018 | Volume: 15 | Issue: No issue available | Pages: No page available

10.5888/pcd15.170168 | PMID 29369757 Get It

Gene Expression Signatures Characterized by Longitudinal Stability and Interindividual Variability Delineate Baseline Phenotypic Groups with Distinct Responses to Immune Stimulation
Scheid, Adam D. , Keulen, Virginia P. Van , Felts, Sara J. , Neier, Steven C. , Middha, Sumit , Nair, Asha, Techentin, Robert W., Gilbert, Barry K., Jen, Jin , Neuhauser, Claudia , Zhang, Yuji , Pease, Larry R. , Van Keulen, Virginia P , Nair, Asha A, Neuhauser, Claudia

Mayo Clinic

The Journal of Immunology | January 19, 2018 | Volume: 200 | Issue: 5 | Pages: 1917-1928

10.4049/jimmunol.1701099 | PMID 29352003 Get It

Abstract Human immunity exhibits remarkable heterogeneity among individuals, which engenders variable responses to immune perturbations in human populations. Population studies reveal that, in addition to interindividual heterogeneity, systemic immune signatures display longitudinal stability within individuals, and these signatures may reliably dictate how given individuals respond to immune perturbations. We hypothesize that analyzing relationships among these signatures at the population level may uncover baseline immune phenotypes that correspond with response outcomes to immune stimuli. To test this, we quantified global gene expression in peripheral blood CD4+ cells from healthy individuals at baseline and following CD3/CD28 stimulation at two time points 1 mo apart. Systemic CD4+ cell baseline and poststimulation molecular immune response signatures (MIRS) were defined by identifying genes expressed at levels that were stable between time points within individuals and differential among individuals in each state. Iterative differential gene expression analyses between all possible phenotypic groupings of at least three individuals using the baseline and stimulated MIRS gene sets revealed shared baseline and response phenotypic groupings, indicating the baseline MIRS contained determinants of immune responsiveness. Furthermore, significant numbers of shared phenotype-defining sets of determinants were identified in baseline data across independent healthy cohorts. Combining the cohorts and repeating the analyses resulted in identification of over 6000 baseline immune phenotypic groups, implying that the MIRS concept may be useful in many immune perturbation contexts. These findings demonstrate that patterns in complex gene expression variability can be used to define immune phenotypes and discover determinants of immune responsiveness.
Untangling the complexity of limb‐girdle muscular dystrophies
Liewluck, Teerin , Milone, Margherita , Liewluck, T

Mayo Clinic

Muscle & Nerve | January 19, 2018 | Volume: 58 | Issue: 2 | Pages: 167-177

10.1002/mus.26077 | PMID 29350766 Get It

ABSTRACTThe limb‐girdle muscular dystrophies (LGMDs) are a group of genetically heterogeneous, autosomal inherited muscular dystrophies with a childhood to adult onset, manifesting with hip‐ and shoulder‐girdle muscle weakness. When the term LGMD was first conceptualized in 1954, it was thought to be a single entity. Currently, there are 8 autosomal dominant (LGMD1A–1H) and 26 autosomal recessive (LGMD2A–2Z) variants according to the Online Mendelian Inheritance in Man database. In addition, there are other genetically identified muscular dystrophies with an LGMD phenotype not yet classified as LGMD. This highlights the entanglement of LGMDs, which represents an area in continuous expansion. Herein we aim to simplify the complexity of LGMDs by subgrouping them on the basis of the underlying defective protein and impaired function. Muscle Nerve 58: 167–177, 2018
Delay to Colectomy and Survival for Patients Diagnosed with Colon Cancer
Diehl, Nancy N. , Parker, Alexander S. , Wasif, Nabil , Parker, Alexander, Bagaria, Sanjay P. , Heckman, Michael G.

Mayo Clinic

Journal of Investigative Surgery | January 19, 2018 | Volume: 32 | Issue: 4 | Pages: 350-357

10.1080/08941939.2017.1421732 | PMID 29351008 Get It

The natural history of complete spinal cord injury: a pooled analysis of 1162 patients and a meta-analysis of modern data
Tecle, Najib E. El , Dahdaleh, Nader S. , Bydon, Mohamad , Ray, Wilson Z. , Torner, James C., Hitchon, Patrick W. , Torner, James C.

Mayo Clinic

Journal of Neurosurgery: Spine | January 19, 2018 | Volume: 28 | Issue: 4 | Pages: 436-443

10.3171/2017.7.spine17107 | PMID 29350593 Get It

OBJECTIVEThe natural history of complete spinal cord injury (SCI) is poorly studied. The classically quoted rate of improvement or conversion for patients with American Spinal Injury Association (ASIA) grade A (ASIA A) injuries is 15%–20%; however, data supporting this rate are very limited. In this paper, the authors conducted a meta-analysis of modern data reporting on ASIA A patients and evaluated factors affecting the natural history of the disease.METHODSThe authors conducted a systematic literature review of all randomized clinical trials (RCTs) and observational studies of patients with traumatic SCI. The Embase, MEDLINE, PubMed, Scopus, CINAHL, and Cochrane databases were reviewed for all studies reporting on SCI and published after 1992. A meta-analysis was conducted using the DerSimonian and Laird (random-effects) model with a summary odds ratio analysis.RESULTSEleven RCTs and 9 observational studies were included in the final analysis. Overall, the 20 included studies reported on 1162 patients with ASIA A injuries. The overall conversion rate was 28.1%, with 327 of 1162 patients improving to at least ASIA B. The overall rate of conversion noted in cervical spine injuries was 33.3%, whereas that in thoracic injuries was 30.6%. Patients undergoing early surgery had a higher rate of conversion (46.1%) than patients undergoing late surgery (25%) (OR 2.31, 95% CI 1.08–4.96, p = 0.03).CONCLUSIONSThe overall rate of conversion of ASIA A SCIs from pooled data of prospective trials and observational series is 28.1%. This rate of conversion is higher than what is reported in the literature. Early surgery is predictive of a higher conversion rate. However, there are not enough data to provide conclusions pertaining to the efficacy of biological and medical therapies.